Showing 1,521 - 1,540 results of 24,535 for search 'LiveAD~', query time: 5.33s Refine Results
  1. 1521

    Model of Liver Fibrosis Induction by Thioacetamide in Rats for Regenerative Therapy Studies by Nathaly Enciso, José Amiel, Fredy Fabián-Domínguez, Jhon Pando, Nancy Rojas, Carlos Cisneros-Huamaní, Ernesto Nava, Javier Enciso

    Published 2022-01-01
    “…Finally, transplanted cells in the fibrous liver were detected. We conclude that TAA applied using the protocol introduced in this study induces a good model of advanced liver fibrosis in rats.…”
    Get full text
    Article
  2. 1522

    Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis by Melanie D Beaton

    Published 2012-01-01
    “…Nonalcoholic fatty liver disease is the leading cause of liver disease in western society. …”
    Get full text
    Article
  3. 1523

    Donor-derived Cryptococcus gattii complex infection after liver transplantation by Bruno Hassunuma Carneiro, Giovanni Luis Breda, Regielly Caroline Raimundo Cognialli, Germana Davila dos Santos, Vania Aparecida Vicente, Eduardo Gnoatto Perondi, João Cesar Beenke França, Flávio Queiroz-Telles

    Published 2025-01-01
    “…Donor-derived Cryptococcus spp. infection typically manifests within the first month post-procedure and has historically been caused by C. neoformans complex, predominantly in kidney recipients, but also after liver transplantation. We report the first documented case of donor-derived, early-onset C. gattii complex meningoencephalitis following liver transplantation in a 54-year-old woman, successfully treated with amphotericin B and fluconazole, and review the relevant literature.…”
    Get full text
    Article
  4. 1524

    Primary Pleomorphic Liposarcoma of Liver: A Case Report and Review of the Literature by P. R. Thippeswamy Naik, Prem Kumar, P. Vinod Kumar

    Published 2013-01-01
    “…Primary liver liposarcoma is a rare disease. The knowledge of the clinical course, management, and prognosis of primary liver liposarcoma are all limited because of its rarity. …”
    Get full text
    Article
  5. 1525
  6. 1526

    Severe Drug-Induced Liver Injury from Combination Encorafenib/Binimetinib by Nicholas Gravbrot, Srinath Sundararajan

    Published 2019-01-01
    “…He was successfully treated by withdrawing the combination therapy, and liver function returned to normal range.…”
    Get full text
    Article
  7. 1527
  8. 1528
  9. 1529
  10. 1530

    Herbicide Widespread: The Effects of Pethoxamid on Nonalcoholic Fatty Liver Steatosis In Vitro by Anna Virginia Adriana Pirozzi, Antonietta Stellavato, Chiara Schiraldi, Mariateresa Giuliano

    Published 2020-01-01
    “…Due to similarities to glyphosate, we did look at the effect of pethoxamid on impaired liver cells HepG2, using a nonalcoholic fatty liver disease (NAFLD) cell model in vitro. …”
    Get full text
    Article
  11. 1531

    Plasmapheresis for Spur Cell Anemia in a Patient with Alcoholic Liver Cirrhosis by Kenji Miki, Takashi Maruki, Shinsaku Imashuku

    Published 2018-01-01
    “…Spur cell anemia (SCA) is a cause of hemolytic anemia in patients with alcoholic liver cirrhosis. Because dyslipidemia is related to the development of spur cells, SCA was previously treated with plasmapheresis. …”
    Get full text
    Article
  12. 1532
  13. 1533

    Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases by Maartje A. J. van den Broek, Steven W. M. Olde Damink, Ann Driessen, Cornelis H. C. Dejong, Marc H. A. Bemelmans

    Published 2009-01-01
    “…Liver resection is the only curative treatment for patients with colorectal liver metastases (CLMs). …”
    Get full text
    Article
  14. 1534

    Fatty liver syndrome associated with some post parturation period diseases by Veysi Aslan, Reşat Aştı, Mehmet Nizamlıoğlu, Tevfik Tekeli, Abdullah Başoğlu, Ülker Demirci

    “…<p> After clinical examination, the blood and liver biopsy samples were obtained. Glucose, GOT', FFA and total lipid values of blood samples and liver fat were measured. …”
    Get full text
    Article
  15. 1535
  16. 1536

    Tocilizumab-Induced Acute Liver Injury in Adult Onset Still’s Disease by Michael Drepper, Laura Rubbia-Brandt, Laurent Spahr

    Published 2013-01-01
    “…Tocilizumab, a monoclonal humanized anti-IL-6 receptor antibody, is used in treatment of refractory adult onset Still’s disease (AOSD). Mild to moderate liver enzyme elevation is a well-known side effect, but severe liver injury has only been reported in 3 cases in the literature. …”
    Get full text
    Article
  17. 1537

    Treatment of Acute Graft-versus-Host Disease in Liver Transplant Recipients by Edward Kim, Alina Adeel, Adel Bozorgzadeh, Shinya Amano, Curtis T. Barry, Jennifer S. Daly, Deepika Devuni, Zendee Elaba, Laura Houk, Paulo N. Martins, Babak Movahedi, Muthalagu Ramanathan, Nicole M. Theodoropoulos

    Published 2021-01-01
    “…Acute graft-versus-host disease (aGvHD) is a rare complication of liver transplantation associated with high morbidity and mortality. …”
    Get full text
    Article
  18. 1538

    Comparison Of ALT In Type 2 Diabetics with And Without Fatty Liver Disease by Kausar Malik, Faiza Batool, Lubna Meraj, Shazia Saddiq, Abrar Akbar, Hina Hanif Mughal

    Published 2023-06-01
    “… Objective: To determine the association of alanine aminotransferase in type 2 diabetic patients with and without fatty liver disease. Materials and Methods: A cross-sectional study was done for six months at Sheikh Khalifa Bin Zaid Al-Nahyan Hospital Rawalakot. …”
    Get full text
    Article
  19. 1539

    The Assessment of Cholinesterase from the Liver of Puntius Javanicus as Detection of Metal Ions by Mohd Khalizan Sabullah, Mohd Rosni Sulaiman, Mohd Yunus Abd Shukor, Mohd Arif Syed, Nor Aripin Shamaan, Ariff Khalid, Siti Aqlima Ahmad

    Published 2014-01-01
    “…Crude extract of ChE from the liver of Puntius javanicus was purified using procainamide-sepharyl 6B. …”
    Get full text
    Article
  20. 1540

    Inhibition of MEK1 Signaling Pathway in the Liver Ameliorates Insulin Resistance by Atsunori Ueyama, Nobuhiro Ban, Masanori Fukazawa, Tohru Hirayama, Minako Takeda, Tatsuo Yata, Hiroyasu Muramatsu, Masaki Hoshino, Marii Yamamoto, Masao Matsuo, Yuka Kawashima, Tatsuhiko Iwase, Takehisa Kitazawa, Youichi Kushima, Yuichiro Yamada, Yoshiki Kawabe

    Published 2016-01-01
    “…A hyperinsulinemic-euglycemic clamp test showed increased glucose infusion rate (GIR) in db/db mice treated with these compounds, and about 60% of the increase was attributed to the inhibition of endogenous glucose production, suggesting that the liver is responsible for the improvement of IR. By means of adenovirus-mediated Mek1 shRNA expression, we confirmed that blood glucose levels are reduced by suppression of MEK1 expression in the liver of db/db mice. …”
    Get full text
    Article